Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…operative durvalumab for resectable non-small-cell lung cancer. N Engl J Med. 2023 Nov 2;389(18):1672–1684.Cascone T, Awad MM, Spicer JD, He…
…ar dystrophy. What about the haemoglobinopathies? Hana R et al (N Engl J Med 2026;394:1281-1291. DOI: 10.1056/NEJMoa2415550) have looked at …
…ated adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158–168.Schadendorf D, van Akkooi ACJ, Blank CU, e…
…rm-based meta-analysis using structured adverse event data from ClinicalTrials.gov (2014–2025). Seventy-seven monotherapy arms (n=8,684 patients) …
…the Institutional Animal Care and Use Committees (IACUC) of the UT Southwestern Medical Center. Clinical samples and data were collected as part of a prospect…
…tis. (Abstract). 2024;18:i17–i18.Loftus EV Jr., Panés J, et al. N Engl J Med. 2023;88:1966–80.…
… Zimmerli W, Trampuz A. Prosthetic-joint-associated infections. N Engl J Med. 2004;351(16):1645–1654.Conflict of Interest No conflict of int…
…nclear if a single dose is sufficient for preventing infection. Kreimer AR et al (N Engl J Med 2025; 393:2421–2433, DOI: 10.1056/NEJMoa2506765) …
…- guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11):991–1001…
…ls.5 Methods We conducted a retrospective cohort analysis using SEER 18 (2005–2017), identifying patients diagnosed with AJCC stage IV …
…N, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387:205-216.…